Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Fourth Quarter and Record Full-Year Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Prestige Brands (PBH) Tops Q4 EPS by 1c, Revenues Beat; Offers FY22 EPS/Revenues Guidance Above Consensus
May 6, 2021 6:31 AM EDTPrestige Brands (NYSE: PBH) reported Q4 EPS of $0.79, $0.01 better than the analyst estimate of $0.78. Revenue for the quarter came in at $237.8 million versus the consensus estimate of $229.9 million.
Fourth Fiscal Quarter Ended March 31, 2021
Reported revenues in the fourth quarter of fiscal 2021 decreased 5.4% to $237.8 million versus $251.2 million in the fourth quarter of fiscal 2020. Revenues decreased 6.6% excluding the impact of foreign currency. The revenue performance for the quarter was driven by strong performance across the majority of the Companys key brands versus their respective categories, but was more than offset by reduced... More
